MedTrace Logo

EmbryoGlue as an Embryo Transfer Medium

NCT03332680 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 730

Last updated 2018-11-30

No results posted yet for this study

Summary

In Vitro Fertilisation (IVF) is an increasingly common treatment for infertility. Clinics which offer IVF are continuously trying to improve their success rates, measured by the numbers of IVF cycles which result in the birth of a live baby.

One factor which is thought to have contributed to the success of IVF is the improvements in the embryo culture media, that is, the fluid in which the embryo resides in the laboratory before being replaced into a woman's womb. This trial seeks to identify if IVF cycles in which a particular culture media called EmbryoGlue is used have better results when compared to IVF cycles in which a conventional embryo transfer media is used.

Conditions

Interventions

BIOLOGICAL

EmbryoGlue® (laboratory culture medium)

Embryos placed in this medium prior to transfer

BIOLOGICAL

Standard control medium

Embryos placed in this medium prior to transfer

Sponsors & Collaborators

  • Oxford Fertility Limited, United Kingdom

    collaborator UNKNOWN

  • University of Oxford

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-16
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03332680 on ClinicalTrials.gov